Dell'Edera Domenico, Benedetto Michele, Gadaleta Gemma, Carone Domenico, Salvatore Donatello, Angione Antonella, Gallo Massimiliano, Milo Michele, Pisaturo Maria Laura, Di Pierro Giuseppe, Mazzone Eleonora, Epifania Annunziata Anna
Unit of Cytogenetics and Molecular Genetics, 'Maddonna delle Grazie Hospital', street Cattedra Ambulante, 75100 Matera, Italy.
J Med Case Rep. 2014 Oct 10;8:339. doi: 10.1186/1752-1947-8-339.
Cystic fibrosis is the most common autosomal recessive genetic disease in the Caucasian population. Extending knowledge about the molecular pathology on the one hand allows better delineation of the mutations in the CFTR gene and the other to dramatically increase the predictive power of molecular testing.
This study reports the results of a molecular screening of cystic fibrosis using DNA samples of patients enrolled from January 2009 to December 2013. Patients were referred to our laboratory for cystic fibrosis screening for infertile couples. In addition, we identified the gene mutations present in 76 patients affected by cystic fibrosis in the pediatric population of Basilicata.
In the 964 infertile couples examined, 132 subjects (69 women and 63 men) resulted heterozygous for one of the CFTR mutations, with a recurrence of carriers of 6.85%. The recurrence of carriers in infertile couples is significantly higher from the hypothetical value of the general population (4%).
This study shows that in the Basilicata region of Italy the CFTR phenotype is caused by a small number of mutations. Our aim is to develop a kit able to detect not less than 96% of CTFR gene mutations so that the relative risk for screened couples is superimposable with respect to the general population.
囊性纤维化是白种人群中最常见的常染色体隐性遗传病。一方面,扩展关于分子病理学的知识有助于更好地描绘囊性纤维化跨膜传导调节因子(CFTR)基因中的突变,另一方面能显著提高分子检测的预测能力。
本研究报告了对2009年1月至2013年12月登记患者的DNA样本进行囊性纤维化分子筛查的结果。患者因不孕不育被转诊至我们实验室进行囊性纤维化筛查。此外,我们还确定了巴西利卡塔地区儿科人群中76例囊性纤维化患者所存在的基因突变。
在接受检查的964对不孕不育夫妇中,132名受试者(69名女性和63名男性)被检测出携带一种CFTR突变的杂合子,携带率为6.85%。不孕不育夫妇中携带者的复发率显著高于一般人群的假设值(4%)。
本研究表明,在意大利的巴西利卡塔地区,CFTR表型是由少数突变引起的。我们的目标是开发一种试剂盒,能够检测不少于96%的CFTR基因突变,从而使接受筛查的夫妇的相对风险与一般人群相当。